EUVIMEDEUVIMED entdecken
Open Access

IL-31–dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis

Marlys S Fassett iD, Joao M Braz iD, Carlos A Castellanos iD, Juan J Salvatierra, Mahsa Sadeghi iD, Xiaobing Yu iD, Andrew W Schroeder, Jaela Caston, Priscila Munoz-Sandoval iD, Suparna Roy iD, Steven Lazarevsky iD, Darryl J Mar iD und 4 weitere

Science Immunology · 27.10.2023 · 8 (88)

DOI: 10.1126/sciimmunol.abi6887 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 27.10.2023. Verfasst von Marlys S Fassett und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of California, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Neurogenic Inflammation. Die Arbeit wurde bisher 86-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite robust literature associating IL-31 with pruritic inflammatory skin diseases, its influence on cutaneous inflammation and the interplay between inflammatory and neurosensory pathways remain unmapped. Here, we examined the consequences of disrupting Il31 and its receptor Il31ra in a mouse model of house dust mite (HDM)–induced allergic dermatitis. Il31 -deficient mice displayed a deficit in HDM dermatitis–associated scratching, consistent with its well-established role as a pruritogen. In contrast, Il31 deficiency increased the number and proportion of cutaneous type 2 cytokine–producing CD4 + T cells and serum IgE in response to HDM. Furthermore, Il4ra + monocytes and macrophages capable of fueling a feedforward type 2 inflammatory loop were selectively enriched in Il31ra -deficient HDM dermatitis skin. Thus, IL-31 is not strictly a proinflammatory cytokine but rather an immunoregulatory factor that limits the magnitude of type 2 inflammatory responses in skin. Our data support a model wherein IL-31 activation of IL31RA + pruritoceptors triggers release of calcitonin gene-related protein (CGRP), which can mediate neurogenic inflammation, inhibit CD4 + T cell proliferation, and reduce T cell production of the type 2 cytokine IL-13. Together, these results illustrate a previously unrecognized neuroimmune pathway that constrains type 2 tissue inflammation in the setting of chronic cutaneous allergen exposure and may explain paradoxical dermatitis flares in atopic patients treated with anti-IL31RA therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicNeurogenic InflammationAnimalsMiceCytokinesImmunityPyroglyphidaeSkinInterleukins

Substanzen

Cytokinesinterleukin-31, mouseInterleukins

Autor:innen und Institutionen

  • Department of Dermatology, University of California, San Francisco, CA, USA.
  • Department of Microbiology and Immunology, University of California, San Francisco, CA, USA.
  • Sandler Asthma Basic Research Center (SABRe), San Francisco, CA, USA.
  • Department of Anatomy, University of California, San Francisco, CA, USA.
  • Department of Anesthesiology, University of California, San Francisco, CA, USA.
  • Howard Hughes Medical Institute, San Francisco, CA 94143, USA.

ORCID-Profile: Marlys S Fassett, Joao M Braz, Carlos A Castellanos, Mahsa Sadeghi, Xiaobing Yu, Priscila Munoz-Sandoval, Suparna Roy, Steven Lazarevsky, Darryl J Mar, Connie J Zhou, Jeoung-Sook Shin, Allan I Basbaum, K Mark Ansel

Förderung

  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIAMS NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Fassett, M. S., Braz, J. M., Castellanos, C. A., Salvatierra, J. J., Sadeghi, M., Yu, X., Schroeder, A. W., Caston, J., Munoz-Sandoval, P., Roy, S., Lazarevsky, S., Mar, D. J., Zhou, C. J., Shin, J. S., Basbaum, A. I., & Ansel, K. M. (2023). IL-31–dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis. Science Immunology, 8(88). https://doi.org/10.1126/sciimmunol.abi6887

Vancouver

Fassett MS, Braz JM, Castellanos CA, Salvatierra JJ, Sadeghi M, Yu X, et al. IL-31–dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis. Science Immunology. 2023;8(88). doi:10.1126/sciimmunol.abi6887

BibTeX
@article{Fassett2023,
  author = {Fassett, Marlys S and Braz, Joao M and Castellanos, Carlos A and Salvatierra, Juan J and Sadeghi, Mahsa and Yu, Xiaobing and Schroeder, Andrew W and Caston, Jaela and Munoz-Sandoval, Priscila and Roy, Suparna and Lazarevsky, Steven and Mar, Darryl J and Zhou, Connie J and Shin, Jeoung-Sook and Basbaum, Allan I and Ansel, K Mark},
  title = {IL-31–dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis},
  journal = {Science Immunology},
  year = {2023},
  volume = {8},
  number = {88},
  doi = {10.1126/sciimmunol.abi6887}
}
Kostenlos starten →